Paras Healthcare Ltd
₹
- close price
About
[
edit about
]
[
add key points
]
- Market Cap ₹ 7,498 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 171
- Book Value ₹
- Dividend Yield %
- ROCE 11.8 %
- ROE 13.0 %
- Face Value ₹ 1.00
Pros
Cons
- Company has low interest coverage ratio.
- Company has a low return on equity of -3.55% over last 3 years.
- Debtor days have increased from 65.4 to 79.4 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Loading peers table ...
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 918 | 1,129 | 1,294 | 1,606 | |
| 846 | 994 | 1,155 | 1,290 | |
| Operating Profit | 71 | 135 | 139 | 316 |
| OPM % | 8% | 12% | 11% | 20% |
| 18 | 22 | 20 | 23 | |
| Interest | 51 | 69 | 94 | 119 |
| Depreciation | 65 | 81 | 116 | 144 |
| Profit before tax | -27 | 7 | -50 | 76 |
| Tax % | 58% | 331% | 16% | 42% |
| -43 | -15 | -58 | 44 | |
| EPS in Rs | -4.38 | -1.57 | -5.94 | 4.34 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 21% |
| TTM: | 24% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 45% |
| TTM: | 176% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -4% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 4 | 10 | 10 | 10 |
| Reserves | 26 | 329 | 271 | 385 |
| 756 | 548 | 1,232 | 1,394 | |
| 507 | 592 | 298 | 282 | |
| Total Liabilities | 1,293 | 1,478 | 1,810 | 2,071 |
| 780 | 988 | 1,173 | 1,211 | |
| CWIP | 78 | 29 | 38 | 29 |
| Investments | 0 | 0 | 0 | 0 |
| 435 | 461 | 599 | 832 | |
| Total Assets | 1,293 | 1,478 | 1,810 | 2,071 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 44 | 92 | 86 | 164 | |
| -126 | -194 | -147 | -239 | |
| 97 | 94 | 83 | 86 | |
| Net Cash Flow | 15 | -8 | 22 | 10 |
| Free Cash Flow | -69 | -102 | -49 | -5 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 106% | 76% | 69% | 69% |
Ratios
Consolidated / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 52 | 51 | 66 | 79 |
| Inventory Days | 27 | 34 | 28 | 27 |
| Days Payable | 191 | 169 | 206 | 177 |
| Cash Conversion Cycle | -112 | -84 | -112 | -70 |
| Working Capital Days | -184 | -67 | -87 | -56 |
| ROCE % | 9% | 4% | 12% |